Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

Published Date: 22 Sep 2023

Momelotinib has received FDA approval for the treatment of intermediate or high-risk myelofibrosis, including primary.

Read Full News

Latest News

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

US Mental Health Treatment Rates Rise But Gaps Persist

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

Cognitive Bias Modification App Fosters Alcohol Avoidance

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Latest News

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Consistently low PSA levels failed to signal metastasis

News All Time

Booze and Pancreatic Cancer Risk; From 'Hospice' to 'Hope'; Gen Z-ers Skip Screening

News, features, and commentary about cancer-related issues

Tennessee Pharmacies Sell Potent Ivermectin Pushed by Anti-Vaccine Doctor

"I've taken bucketloads of this stuff," says Denise Sibley

More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.

A look at the "silent" impacts of cancer

More Data Back Teclistamab for Autoimmune Disease

Another case series shows most patients improved markedly after failing everything else

Multicomponent Test Tops PSA for Clinically Significant Prostate Cancers

Blood-based biomarker test had similar false-positive rate as PSA, while reducing false negatives

'The Pitt' Actor's Cancer Diagnosis; New HHS Research Plans; Madonna Reveals Injury

Health news and commentary gathered by MedPage Today staff

Nature Retracts Cancer Study Suggesting Treatment Is Better Earlier in the Day

Editors "no longer have confidence in the integrity of the results"

Long-Term CAR-T Results in Lymphoma Confirm Early Promise

Lymphoma-free survival exceeding 5 years in early recipients of the cellular therapy

I Watched My Friend Choose Death. Physician-Assisted Suicide Needs More Guardrails.

And the fundamental question remains of whether doctors should be involved at all

Scream, It's Good for You; Release the Cancer Pigeons; Talk of Chemo Rationing

News, features, and commentary about cancer-related issues

A Cancer Patient's Cats Inspired a Push for Pets in Hospice Wards

The presence of a beloved pet can ease the pain of terminally ill patients, says one doctor

Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends

Also in TTHealthWatch: tranexamic acid in routine surgery

Study Homes In on Simpler Lung Cancer Screening Criteria

Researchers find benefits, trade-offs using various levels of smoking duration alone

Orca-T Approved to Prevent GVHD After Stem Cell Transplant for Blood Cancers

Regulatory T cell-based immunotherapy approved for use in matched-donor HSCTs

Why Are These Bones and Teeth Where They Shouldn't Be?

Discovery in 31-year-old woman made after she came to the ER with mild abdominal pain

Smoker's Painless Skin Nodules Flag a Fatal Diagnosis

Skin metastasis was the first sign for the otherwise asymptomatic patient

Recommended News For You

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

Older Adults With Advanced Cancer Prioritize Quality of Life

FDA approves rivanetin as the first-line treatment for lung cancer.

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Higher levels of HIF2α found to slow down aggressive childhood cancer

Recommended Articles For You

The Benefits and Risks of Thrombolytics: A Comprehensive Guide  

Comprehensive Updates in Hematology and Quality Improvement 

The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies 

Rehabilitation of Physical Endurance Following Prolonged Cytopenic States 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

2.

One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study

3.

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

4.

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

5.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

1.

Emerging Advances in Hematology and Quality Improvement

2.

Practical Breakthroughs in Oncology Across Clinical Settings

3.

Nuclear Medicine's Role in Battling Women's Cancers

4.

Genetic Screening: A Game Changer in Cancer Prevention

5.

Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part VII

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

3.

Signs and Symptoms of Leukemia

4.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot